Stockscreener 앱 받기
2.94
13.78%
-0.47
전일 마감가:
$3.41
열려 있는:
$3.2
하루 거래량:
691.11K
Relative Volume:
0.26
시가총액:
$15.34M
수익:
$9.37M
순이익/손실:
$-8.45M
주가수익비율:
-3.6296
EPS:
-0.81
순현금흐름:
$-7.27M
1주 성능:
+8.09%
1개월 성능:
-46.33%
6개월 성능:
-80.97%
1년 성능:
-95.40%
1일 변동 폭
$2.94
$3.2199
1주일 범위
$2.55
$3.50
52주 변동 폭
$2.3401
$67.12
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
BIAF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
2.94 | 15.34M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
538.92 | 202.69B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
209.06 | 151.03B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
635.40 | 50.99B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.92 | 40.00B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.55 | 34.98B | 15.70B | 1.24B | 2.01B | 6.9036 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
Will bioAffinity Technologies Inc. stock maintain momentum in 2025M&A Rumor & AI Powered Market Entry Strategies - Trung tâm Dự báo KTTV quốc gia
Can trapped investors hope for a rebound in bioAffinity Technologies Inc. Equity WarrantTrade Volume Summary & Weekly High Momentum Picks - newser.com
Has bioAffinity Technologies Inc. Equity Warrant found a price floorQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
How to interpret RSI for bioAffinity Technologies Inc. stockEarnings Trend Report & High Conviction Investment Ideas - newser.com
Predicting bioAffinity Technologies Inc. Equity Warrant trend using moving averagesMarket Volume Summary & Stepwise Entry/Exit Trade Alerts - newser.com
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer - BioSpace
Why Did bioAffinity Technologies' Stock Slip In After-Hours Trading After A Big Day Of Gains? - Benzinga
Forecasting bioAffinity Technologies Inc. Equity Warrant price range with options dataTrade Exit Report & Verified Swing Trading Watchlists - newser.com
What high frequency data says about bioAffinity Technologies Inc.2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
BioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer - MarketScreener
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Dia - PharmiWeb.com
bioAffinity stock soars after receiving patent allowance for AI lung cancer test - Investing.com Australia
bioAffinity Technologies Secures Patent for Lung Cancer Detection - TipRanks
bioAffinity Technologies Announces U.S. Patent Allowance for Lung Cancer Detection Method - TradingView
BIAF announces USPTO notice of allowance for sputum-based test patent - Stock Titan
bioAffinity Technologies regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Is it time to cut losses on bioAffinity Technologies Inc.July 2025 Outlook & Consistent Profit Alerts - newser.com
Intraday pattern recognizer results for bioAffinity Technologies Inc. Equity Warrant2025 Market Trends & Community Supported Trade Ideas - newser.com
Is bioAffinity Technologies Inc. Equity Warrant stock a good choice for value investors2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trends2025 Key Lessons & Smart Money Movement Tracker - newser.com
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - PharmiWeb.com
Will bioAffinity Technologies Inc. Equity Warrant stock remain a Wall Street favorite2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com
Will bioAffinity Technologies Inc. stock deliver better than expected guidanceAnalyst Upgrade & Stock Market Timing Techniques - newser.com
bioAffinity Regains Nasdaq Compliance, Ensures Continued Trading - TipRanks
bioAffinity Technologies Regains Nasdaq Compliance - TradingView
BIAF back in compliance with Nasdaq bid price and equity rules - Stock Titan
bioAffinity Technologies regains Nasdaq compliance - Investing.com
bioAffinity Technologies Completes $4.8M Stock Offering - MSN
What recovery options are there for bioAffinity Technologies Inc.Day Trade & Smart Allocation Stock Tips - newser.com
Detecting price anomalies in bioAffinity Technologies Inc. Equity Warrant with AI2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
bioAffinity Technologies Appoints New Board Members - MSN
How institutional buying supports bioAffinity Technologies Inc. Equity Warrant stockWeekly Loss Report & Safe Capital Growth Tips - newser.com
Can trapped investors hope for a rebound in bioAffinity Technologies Inc.CPI Data & Daily Profit Maximizing Tips - newser.com
BioAffinity Technologies announces $1.8M registered direct offering - MSN
Will bioAffinity Technologies Inc. Equity Warrant stock beat EPS estimatesMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Why bioAffinity Technologies Inc. stock is in analyst buy zoneWall Street Watch & Low Drawdown Trading Strategies - newser.com
bioAffinity Technologies, Inc.Warrant (NQ: BIAFW - FinancialContent
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
1.44%
자본화:
|
볼륨(24시간):